Delivery Order SPE2DR25D3103-SPE2DR26F9F22
Award Date 11/13/25
Potential Completion Date 12/5/25
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Andexxa 200 mg vials, valued at $41,589.24 with a firm fixed price structure. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 umbrella value and extends through December 2026. The delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Andexxa 200 mg vials, a critical reversal agent used in emergency medical settings. Valued at $17,344.30 with a firm fixed price structure, this non-set-aside competitive award reflects AmerisourceBergen's established capability as a major pharmaceutical distributor supporting federal healthcare systems. The contract is scheduled for completion by December 1, 2025, with...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of ANDEXXA 200 MG VIALS. The delivery order, valued at $13,317.46, is a firm-fixed price contract with a completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ANDEXXA 200 mg vials. The contract, valued at $19,976.19, is a firm-fixed-price delivery order with an ultimate completion date of August 21, 2024. The award was made on July 31, 2024, and there was no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $79,161.66 firm fixed-price delivery order is for the supply of ANDEXXA 200 MG VIALS. The contract has an ultimate completion date of November 18, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $31,726.08 to AmerisourceBergen Drug Corp on November 1, 2025, with an ultimate completion date of November 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,363.11 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order is a non-set-aside award issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Tranexamic 1,000 mg/100mL-NaCl 100mL, a pharmaceutical product used primarily for hemorrhage control and bleeding management in military and medical settings. This firm fixed price delivery order, valued at $1,023.95, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $40,227 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $58,002.00 to AmerisourceBergen Drug Corp on November 8, 2025, with completion targeted for November 10, 2025. This firm fixed-price delivery order, issued without set-aside designation, leverages AmerisourceBergen's position as a critical pharmaceutical distributor supporting federal medical procurement. The work will be performed at the contractor's corporate office location in Conshohocken,...